Skip to content

Clinical trials

Phase 3 Anemia, Sickle Cell trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 3 Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20163
20181
20191
20201
20213
20221
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Active, not recruiting3
Terminated3
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris4
Pfizer4
Novo Nordisk A/S2
Forma Therapeutics, Inc.1
Icagen1
Nantes University Hospital1
Novartis Pharmaceuticals1
Sanofi1
University Hospital, Geneva1
University Hospital, Rouen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell18
Vaso-Occlusive Crises7
Hematologic Diseases4
Sickle Cell Trait4
Acute Chest Syndrome3
Anemia2
Agnosia1
Anemia, Hemolytic1
Genetic Diseases, Inborn1
Hemoglobinopathies1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.